Furthermore, virtually all molecular or nanoparticle-based therapies are inaccessible to the hypoxic areas of tumors that lack blood flow thus limiting the treatment efficacy
Furthermore, virtually all molecular or nanoparticle-based therapies are inaccessible to the hypoxic areasof tumors that lack blood flow thus limiting the treatment efficacy